Global Pediatric Asthma Treatment Market
According to Intent Market Research, the Pediatric Asthma Treatment Market is expected to grow from USD 4.8 Billion in 2024-e at a CAGR of 15.7% to touch USD 11.6 Billion by 2030. The Pediatric Asthma Treatment Market is dominated by key players such as Merck & Co., Inc., Novartis, AstraZeneca, Johnson & Johnson, Teva Pharmaceuticals, and Boehringer Ingelheim